Estela Vega
-
- Cancer Genomics and Diagnostics 4
-
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
-
- Advanced Breast Cancer Therapies 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Radiomics and Machine Learning in Medical Imaging 2
- Co-authors
- Eva CiruelosH. Cortés-FunesLuís MansoTomás PascualManuel HidalgoJesús Rodríguez-PascualAntonio CubilloRodrigo A. Toledo
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (6 papers)Clinical Cancer Research (1 paper)
- Partner nations
- SpainUnited StatesPalestinian Territory
In The Last Decade
Estela Vega
21 papers receiving 159 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 71
- Oncology 116
- Pathology and Forensic Medicine 34
- Pulmonary and Respiratory Medicine 56
- Genetics 28
Countries citing papers authored by Estela Vega
This map shows the geographic impact of Estela Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estela Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estela Vega more than expected).
Fields of papers citing papers by Estela Vega
This network shows the impact of papers produced by Estela Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estela Vega. The network helps show where Estela Vega may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Estela Vega, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 3 | |
| 11 | Neoadjuvant Chemoradiation for Unfavourable Breast Cancer Patients: A Prospective Cohort Study | 2019 | 1 |
| 12 | 2018 | 3 | |
| 13 | 2018 | 6 | |
| 14 | 2016 | 2 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 46 | |
| 17 | 2016 | 4 | |
| 18 | 2014 | 52 | |
| 19 | 2012 | 10 | |
| 20 | 2011 | 1 |
About Estela Vega
Estela Vega is a scholar working on Oncology, Cancer Research and Hepatology, having authored 22 papers that have together received 162 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Cancer Research (71 citations), Oncology (116 citations) and Pathology and Forensic Medicine (34 citations). Estela Vega has collaborated with scholars based in Spain, United States and Palestinian Territory. Frequent co-authors include Eva Ciruelos, H. Cortés-Funes, Luís Manso, Tomás Pascual, Manuel Hidalgo, Jesús Rodríguez-Pascual, Antonio Cubillo, Rodrigo A. Toledo, Fernando López‐Ríos and Sofía Perea. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.